Delivery Order SPE2DR25D9331-SPE2DR26FQQK5
Award Date 3/2/26
Potential Completion Date 3/23/26
Potential Value $18K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $6,134.90 delivery order to DMS Pharmaceutical Group Inc. on February 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for Photrexa Cross-Linking Kit 6ML. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group Inc. is a...
- The Defense Logistics Agency issued a $15,337.25 delivery order to DMS Pharmaceutical Group Inc. on February 11, 2026, for Photrexa cross-linking kit 6ml under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. DMS Pharmaceutical Group Inc....
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 18, 2026, for $30,674.50 to supply Photrexa cross-linking kit (6 mL) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations worldwide. DMS...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 10, 2026, for $15,337.25 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of Photrexa Cross-Linking Kit 6ml. PPV-G GEN V is the Defense Logistics Agency's pharmaceutical prime vendor program, structured as a single-award indefinite delivery contract with a $499.9 billion ceiling authorizing firm fixed-price delivery orders for branded and generic...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, with a ceiling value of $18,404.70 for Photrexa cross-linking kit 6ml, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. PPV-G GEN V is a DLA-administered pharmaceutical supply contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 18, 2026, with a ceiling value of $3,067.45 for supply of Photrexa Cross-Linking Kit 6ml. The delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support...
- The Defense Logistics Agency issued a $18,404.70 delivery order to DMS Pharmaceutical Group Inc. on February 2, 2026, for Photrexa Cross-Linking Kit 6ML, with an ultimate completion date of February 24, 2026. This delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical...
- The Defense Logistics Agency issued a $30,674.50 delivery order to DMS Pharmaceutical Group Inc. on February 5, 2026, for Photrexa cross-linking kit 6ml, with an ultimate completion date of February 27, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 23, 2026, for Photrexa Cross-Linking Kit 6ML with a ceiling value of $12,269.80, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The order is firm fixed price with an ultimate completion date of March 16, 2026. Place of performance is Park Ridge, IL. The PPV-G GEN V is a Defense...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 10, 2026, for Photrexa Cross-Linking Kit 6ml, with a ceiling value of $3,067.45 and firm fixed-price terms. DMS Pharmaceutical Group is a woman-owned small business. The delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499.999 billion ceiling through December 31,...